mpa ku adult medicine patient portal

What is the difference between KU Medical Center and University of Kansas?

KU Medical Center partners with clinical care organizations in Kansas City, Salina, Wichita and beyond. The University of Kansas Medical Center serves as the health sciences campus for the University of Kansas.

Why choose Ku Wichita internal medicine Midtown?

throughout all of the Wichita area. KU Wichita Internal Medicine Midtown provides primary care services by University of Kansas School of Medicine-Wichita faculty. The entire staff functions as a team to make your visit as pleasant and efficient as possible.

Why join a Ku MPa?

Join the hundreds of KU MPAs making a difference by leading locally, nationally, and globally. Are You Ready to Make a Difference?

Why Ku public affairs and administration?

At the KU School of Public Affairs and Administration, our mission is to educate exceptional public professionals and generate thought leadership that provides solutions to the most pressing global and community challenges by advancing the public good, democratic values, and ethical public management practices.

Welcome to KU Wichita Internal Medicine

KU Wichita Internal Medicine Midtown provides primary care services by University of Kansas School of Medicine-Wichita faculty.

Our Office Staff

The entire staff functions as a team to make your visit as pleasant and efficient as possible. We take pride in the training, knowledge, skills, and professionalism of our team, and we trust that you will share this feeling of confidence.

Phone Messages

Our faculty and resident physicians are at a number of facilities throughout the week. Our nurses will routinely contact doctors during the day and relay your messages. Unless it is an emergency, expect a response later in the day.

Clinical trial of COVID-19 vaccine resuming at KU Wichita Center for Clinical Research

The University of Kansas School of Medicine-Wichita Center for Clinical Research has resumed leading the local effort of a nationwide clinical trial brought through the COVID-19 Prevention Network testing the COVID-19 vaccine AZD1222, developed by Oxford University and purchased by AstraZeneca.